Nasal Dilator Strip is an Effective Placebo Intervention for Severe Obstructive Sleep Apnea.

doi:10.5664/jcsm.6450

Paper

Nasal Dilator Strip is an Effective Placebo Intervention for Severe Obstructive Sleep Apnea.

Published Feb 15, 2017 · F. Yagihara, G. Lorenzi-Filho, R. Santos‐Silva

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

UNKNOWN SJR score

11

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

STUDY OBJECTIVES The aim of this study was to evaluate the effects of nasal dilator strip (NDS) as a placebo intervention compared with continuous positive airway pressure (CPAP) treatment in patients with severe obstructive sleep apnea (OSA). METHODS Patients were treated with both NDS and nasal CPAP. The sequence was randomized and interposed by 15 days of washout. Polysomnography was performed at baseline and on the first night of intervention with NDS and CPAP (titration). The Epworth Sleepiness Scale (ESS), Functional Outcomes of Sleep Questionnaire (FOSQ), and Beck Depression Inventory (BDI) were completed at baseline and at the end of both interventions. A questionnaire on the comfort and satisfaction (0 = no to 10 = total) was completed at the end of each intervention. RESULTS Twenty-six patients with OSA were evaluated (19 male; age 46.3 ± 9.3 y; body mass index 33.2 ± 5.1 kg/m2; ESS 15.8 ± 4.1; apnea-hypopnea index 60.7 ± 25.2). Adherence was high in both NDS (98%) and CPAP interventions (94%; 5.8 ± 1.7 h/night). In contrast to the baseline values, NDS intervention had no significant effect on all polysomnographic parameters, but NDS improved somnolence (ESS 13.0 ± 5.4, p = 0.001) and depressive symptoms (BDI 7.7 ± 6.9, p = 0.005). Reported satisfaction was significantly higher for CPAP than for NDS (sleep quality 9.2 ± 0.8 vs. 6.1 ± 2.1; wake up at morning: 8.6 ± 1.2 vs. 6.0 ± 2.2; daily activities: 8.9 ± 1.4 vs. 5.8 ± 1.5; quality of life: 8.3 ± 2.1 vs. 3.8 ± 3.5, p < 0.001), but similar low levels of difficulty for both interventions were observed (1.3 ± 2.2 vs. 0.3 ± 1.3, p = 0.098). CONCLUSIONS Our data indicate that NDS is an attractive placebo intervention for randomized controlled trials evaluating the effects of CPAP in sleepy patients with OSA.

RCT

Study Snapshot

Nasal dilator strips are an effective placebo intervention for evaluating the effects of CPAP in sleepy patients with severe obstructive sleep apnea, improving somnolence and depressive symptoms.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Nasal Dilator Strip is an Effective Placebo Intervention for Severe Obstructive Sleep Apnea.

Sign up to use Study Snapshot

References

The Epworth Sleepiness Scale in Service Members with Sleep Disorders.

The Epworth Sleepiness Scale (ESS) is poor in separating sleep disorders in military personnel, with elevated scores in common sleep disorders and no clear distinction between obstructive sleep apnea and insomnia.

Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.

Health-service or patient-oriented interventions can improve mental health outcomes for people with multimorbidity in primary care and community settings.

Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study.

Sleep-disordered breathing is highly prevalent in the general population, with significant public health implications and a need for revision of the disorder's definition.

Placebo‐induced decrease in fatigue: evidence for a central action on the preparatory phase of movement

Placebos reduce fatigue by acting centrally during the preparatory phase of movement, emphasizing the central nervous system's role in fatigue generation.

Ethics, consent and blinding: lessons from a placebo/sham controlled CPAP crossover trial

Lack of full disclosure in a CPAP trial led to successful patient blinding, but staff unblinding occurred, highlighting the difficulty in investigator blinding in device-based trials.

Citations

Clinical Review of Commercially-Available Anti-Snoring Devices

Commercially-available anti-snoring devices, such as nasal dilators and chin straps, may not be a viable alternative management option for snoring patients due to a lack of clinical evidence.

Distinguishing science from pseudoscience in commercial respiratory interventions: an evidence-based guide for health and exercise professionals

This review helps health and exercise professionals distinguish science from pseudoscience in commercial respiratory interventions, enabling them to make safe risk-to-benefit decisions for patients and clients.

Improving Nasal Airflow with a Novel Nasal Breathing Stent

The novel nasal breathing stent (NBS) significantly improves nasal airflow compared to existing nasal dilators, offering a decreased resistance to air movement.

The effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - Study design and challenges during the COVID-19 pandemic

The MORPHEOS trial aims to evaluate the blood pressure lowering effects of continuous positive airway pressure (CPAP) in patients with uncontrolled hypertension and obstructive sleep apnea.

Automatic positive airway pressure for obstructive sleep apnea in heart failure with reduced ejection fraction

APAP treatment significantly improves oxygen uptake and quality of life in heart failure patients with reduced ejection fraction.

Patients With OSA Are Perceived as Younger Following Treatment With CPAP.

Patients with severe OSA perceived as younger after 1 month of CPAP treatment, which may serve as a motivational factor for compliance and improved OSA management.

The role of sham continuous positive airway pressure as a placebo in controlled trials: Best Apnea Interventions for Research Trial.

Sham-CPAP showed no significant differences in objectively or subjectively measured outcomes compared to conservative medical therapy, but lower adherence and poorer self-efficacy may suggest differences in perceived benefit.

Cumulative mild partial sleep deprivation negatively impacts working memory capacity but not sustained attention, response inhibition, or decision making: a randomized controlled trial☆

Cumulative mild partial sleep deprivation negatively impacts working memory capacity but does not affect sustained attention, response inhibition, or decision making.

Internal nasal dilator in patients with obstructive sleep apnea syndrome and treated with continuous positive airway pressure

The Nas-air® internal nasal dilator significantly improves adherence and compliance to CPAP in patients with obstructive sleep apnea syndrome.